Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liver Cirrhosis"" wg kryterium: Temat


Starter badań:

Tytuł:
Liver cirrhosis: An overview of experimental models in rodents.
Autorzy:
Faccioli LAP; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Dias ML; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil; Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, INCT-REGENERA, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil.
Paranhos BA; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil; Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, INCT-REGENERA, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil.
Dos Santos Goldenberg RC; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil; Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, INCT-REGENERA, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil. Electronic address: .
Pokaż więcej
Źródło:
Life sciences [Life Sci] 2022 Jul 15; Vol. 301, pp. 120615. Date of Electronic Publication: 2022 May 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Liver Cirrhosis, Experimental*/chemically induced
Rodentia*
Animals ; Carbon Tetrachloride/toxicity ; Disease Models, Animal ; Liver/pathology ; Liver Cirrhosis/pathology ; Models, Theoretical ; Thioacetamide/toxicity
Czasopismo naukowe
Tytuł:
Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative Stress.
Autorzy:
Liu Y; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Kuang Q; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Dai X; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Zhan M; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Zhou L; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.; Modern Life Science Experiment Teaching Center, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Zhu L; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.; Modern Life Science Experiment Teaching Center, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Wang B; Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 12; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carrier Proteins*/genetics
Carrier Proteins*/metabolism
Inflammation*/genetics
Inflammation*/metabolism
Inflammation*/pathology
Intracellular Signaling Peptides and Proteins*/genetics
Intracellular Signaling Peptides and Proteins*/metabolism
Liver Cirrhosis, Alcoholic*/genetics
Liver Cirrhosis, Alcoholic*/metabolism
Oxidative Stress*/genetics
Oxidative Stress*/physiology
Animals ; Humans ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis/metabolism ; Mice ; Mice, Inbred C57BL ; NF-E2-Related Factor 2/metabolism ; NF-kappa B/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł:
Primary biliary cholangitis: advances in understanding and management.
Autorzy:
Smith A; Portsmouth Liver Centre, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
Giles B; Portsmouth Liver Centre, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
Aspinall RJ; Portsmouth Liver Centre, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
Pokaż więcej
Źródło:
British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2022 Mar 02; Vol. 83 (3), pp. 1-9. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/therapy
Humans ; Liver Cirrhosis
Czasopismo naukowe
Tytuł:
Oxidative stress-induced growth inhibitor 1 in alcohol-induced liver cirrhosis.
Autorzy:
Sak JJ; Chair and Department of Humanities and Social Medicine, Medical University, Lublin, Poland.
Prystupa A; Department of Internal Medicine, Medical University, Lublin, Poland.
Bis-Wencel H; Department of Microbiology and Reproductive Biology, University of Life Science, Lublin, Poland.
Kiciński P; Department of Experimental Haematooncology, Medical University, Lublin, Poland.
Luchowska-Kocot D; Department of Medical Chemistry, Medical University, Lublin, Poland.
Krukowski H; Department of Microbiology and Reproductive Biology, University of Life Science, Lublin, Poland.
Nowicki GJ; Department of Family Medicine and Community Nursing, Medical University, Lublin, Poland.
Panasiuk L; Institute of Rural Health, Lublin, Poland.
Pokaż więcej
Źródło:
Annals of agricultural and environmental medicine : AAEM [Ann Agric Environ Med] 2021 Dec 29; Vol. 28 (4), pp. 676-680. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Alcoholic*/etiology
Oxidative Stress*
Child ; Fibrosis ; Growth Inhibitors ; Humans ; Liver Cirrhosis/etiology
Czasopismo naukowe
Tytuł:
Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant.
Autorzy:
Singal AK; Department of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota, USA.; Avera McKennan University Hospital and Transplant Institute, Sioux Falls, South Dakota, USA.
Wong RJ; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford and Veterans Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
Jalan R; Liver Failure Group, Institute for Liver and Digestive Health, UCL Medical School, London, UK.; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain.
Asrani S; Division of Gastroenterology and Hepatology, Baylor University Medical Center, Dallas, Texas, USA.
Kuo YF; Department of Biostatistics and Preventive Medicine, University of Texas Medical Branch, Galveston, USA.
Pokaż więcej
Źródło:
Clinical transplantation [Clin Transplant] 2021 Dec; Vol. 35 (12), pp. e14479. Date of Electronic Publication: 2021 Sep 23.
Typ publikacji:
Journal Article
MeSH Terms:
Acute-On-Chronic Liver Failure*
Liver Cirrhosis, Biliary*/etiology
Liver Cirrhosis, Biliary*/surgery
Liver Transplantation*
Adult ; Humans ; Liver Cirrhosis/etiology ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Minimal hepatic encephalopathy may be present despite the absence of non-invasive and elastography evidence of cirrhosis in patients with primary biliary cholangitis.
Autorzy:
Bogdanowska-Charkiewicz D; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Rogalski P; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland. Electronic address: .
Janica J; Department of Radiology, Medical University of Bialystok, Bialystok, Poland.
Rogalska-Plonska M; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
Aleksiejuk E; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Antonowicz S; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Dabrowski A; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Daniluk J; Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
Pokaż więcej
Źródło:
Advances in medical sciences [Adv Med Sci] 2021 Sep; Vol. 66 (2), pp. 293-301. Date of Electronic Publication: 2021 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Elasticity Imaging Techniques*
Hepatic Encephalopathy*/etiology
Liver Cirrhosis, Biliary*/complications
Humans ; Liver Cirrhosis/complications ; Middle Aged ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification.
Autorzy:
Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.; Institute of Clinical Psychology and Psychotherapy, Center of Clinical Epidemiology and Longitudinal Studies, Technische Universität Dresden, Dresden, Germany.; Department of Psychiatry, University of Toronto, Toronto, Canada.; Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; Program on Substance Abuse, Public Health Agency of Catalonia, Barcelona, Spain.; Department of Psychiatry and Psychotherapy, Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Patra J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Brennan A; School of Health and Related Research, University of Sheffield, Sheffield, UK.
Buckley C; Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, UK.
Greenfield TK; Alcohol Research Group, Public Health Institute, Emeryville, USA.
Kerr WC; Alcohol Research Group, Public Health Institute, Emeryville, USA.
Manthey J; Institute of Clinical Psychology and Psychotherapy, Center of Clinical Epidemiology and Longitudinal Studies, Technische Universität Dresden, Dresden, Germany.; Department of Psychiatry and Psychotherapy, Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Psychiatry, Medical Faculty, University of Leipzig, Leipzig, Germany.
Purshouse RC; Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, UK.
Rovira P; Program on Substance Abuse, Public Health Agency of Catalonia, Barcelona, Spain.
Shuper PA; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Shield KD; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
Pokaż więcej
Źródło:
Drug and alcohol review [Drug Alcohol Rev] 2021 Nov; Vol. 40 (7), pp. 1377-1386. Date of Electronic Publication: 2021 Mar 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Liver Cirrhosis*/etiology
Liver Neoplasms*/complications
Alcohol Drinking/adverse effects ; Alcohol Drinking/epidemiology ; Humans ; Liver Cirrhosis, Alcoholic ; Risk Factors
Czasopismo naukowe
Tytuł:
Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation.
Autorzy:
Thiele M; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Johansen S; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Gudmann NS; Nordic Bioscience A/S, Herlev, Denmark.
Madsen B; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Kjaergaard M; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Nielsen MJ; Nordic Bioscience A/S, Herlev, Denmark.
Leeming DJ; Nordic Bioscience A/S, Herlev, Denmark.
Jacobsen S; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Bendtsen F; Gastro Unit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Hvidovre, Denmark.
Møller S; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Hvidovre, Denmark.; Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
Detlefsen S; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.
Karsdal M; Nordic Bioscience A/S, Herlev, Denmark.; Department of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Krag A; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Corporate Authors:
GALAXY Consortium
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Oct; Vol. 54 (8), pp. 1070-1080. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Collagen*
Liver Cirrhosis*/etiology
Biomarkers ; Extracellular Matrix ; Female ; Fibrosis ; Humans ; Liver Cirrhosis, Alcoholic ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis: A systematic review & meta-analysis.
Autorzy:
Wijarnpreecha K; Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Werlang M; Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Panjawatanan P; Department of Medicine, Bassett Medical Center, Cooperstown, New York, USA.
Pungpapong S; Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Lukens FJ; Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Harnois DM; Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Ungprasert P; Department of Research & Development, Clinical Epidemiology Unit, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
The Indian journal of medical research [Indian J Med Res] 2021 Jun; Vol. 154 (6), pp. 806-812.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/epidemiology
Cross-Sectional Studies ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/epidemiology ; Prospective Studies ; Smoking/adverse effects
Czasopismo naukowe
Tytuł:
Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease.
Autorzy:
Sang C; Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Wang X; E-institute of Shanghai Municipal Education Committee, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhou K; Human Metabolomics Institute, Inc., Shenzhen 518109, Guangdong, China.
Sun T; Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Bian H; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Gao X; Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Wang Y; E-institute of Shanghai Municipal Education Committee, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Zhang H; E-institute of Shanghai Municipal Education Committee, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jia W; Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.; Hong Kong Traditional Chinese Medicine Phenome Research Centre, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong 999077, Hong Kong, China.
Liu P; E-institute of Shanghai Municipal Education Committee, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Xie G; Human Metabolomics Institute, Inc., Shenzhen 518109, Guangdong, China.
Chen T; Center for Translational Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Pokaż więcej
Źródło:
Journal of proteome research [J Proteome Res] 2021 May 07; Vol. 20 (5), pp. 2340-2351. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis, Biliary*/diagnosis
Liver Cirrhosis, Biliary*/etiology
Liver Cirrhosis, Biliary*/pathology
Non-alcoholic Fatty Liver Disease*/etiology
Non-alcoholic Fatty Liver Disease*/pathology
Bile Acids and Salts ; Humans ; Liver/pathology ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Morbimortality Associated with Liver Cirrhosis in Peru: An Ecological Analysis for the Period of 2004-2016.
Autorzy:
Rojas-Acuña D; School of Medicine, Universidad Católica Santo Toribio de Mogrovejo, Chiclayo 14012, Peru.; Asociación Científica Médico Estudiantil USAT, Chiclayo 14012, Peru.
Polo-Samillan N; School of Medicine, Universidad Católica Santo Toribio de Mogrovejo, Chiclayo 14012, Peru.; Asociación Científica Médico Estudiantil USAT, Chiclayo 14012, Peru.
Vasquez-Chavesta AZ; School of Medicine, Universidad Católica Santo Toribio de Mogrovejo, Chiclayo 14012, Peru.; Asociación Científica Médico Estudiantil USAT, Chiclayo 14012, Peru.
Escalante-Arias C; School of Medicine, Universidad Católica Santo Toribio de Mogrovejo, Chiclayo 14012, Peru.; Asociación Científica Médico Estudiantil USAT, Chiclayo 14012, Peru.
Rios-Perez CJ; School of Medicine, Universidad Católica Santo Toribio de Mogrovejo, Chiclayo 14012, Peru.; Asociación Científica Médico Estudiantil USAT, Chiclayo 14012, Peru.
Toro-Huamanchumo CJ; Unidad para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima 15024, Peru.; Clínica Avendaño, Unidad de Investigación Multidisciplinaria, Lima 15074, Peru.
Pokaż więcej
Źródło:
International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Jul 25; Vol. 19 (15). Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Gastrointestinal Hemorrhage*
Liver Cirrhosis*/complications
Liver Cirrhosis*/epidemiology
Humans ; Peru/epidemiology
Czasopismo naukowe
Tytuł:
The altered osteocytic expression of connexin 43 and sclerostin in human cadaveric donors with alcoholic liver cirrhosis: Potential treatment targets.
Autorzy:
Jadzic J; Laboratory of Bone Biology and Bioanthropology, Faculty of Medicine, Institute of Anatomy, University of Belgrade, Belgrade, Serbia.
Milovanovic PD; Laboratory of Bone Biology and Bioanthropology, Faculty of Medicine, Institute of Anatomy, University of Belgrade, Belgrade, Serbia.
Cvetkovic D; Faculty of Medicine, Institute of Forensic Medicine, University of Belgrade, Belgrade, Serbia.
Zivkovic V; Faculty of Medicine, Institute of Forensic Medicine, University of Belgrade, Belgrade, Serbia.
Nikolic S; Faculty of Medicine, Institute of Forensic Medicine, University of Belgrade, Belgrade, Serbia.
Tomanovic N; Faculty of Medicine, Institute of Pathology, University of Belgrade, Belgrade, Serbia.
Djuric MP; Laboratory of Bone Biology and Bioanthropology, Faculty of Medicine, Institute of Anatomy, University of Belgrade, Belgrade, Serbia.
Djonic D; Laboratory of Bone Biology and Bioanthropology, Faculty of Medicine, Institute of Anatomy, University of Belgrade, Belgrade, Serbia.
Pokaż więcej
Źródło:
Journal of anatomy [J Anat] 2022 Jun; Vol. 240 (6), pp. 1162-1173. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptor Proteins, Signal Transducing*/metabolism
Connexin 43*/metabolism
Liver Cirrhosis, Alcoholic*/metabolism
Liver Cirrhosis, Alcoholic*/pathology
Osteocytes*
Adult ; Aged ; Cadaver ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
TSC22D4 promotes TGFβ1-induced activation of hepatic stellate cells.
Autorzy:
Sakurai M; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Weber P; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Research Unit Radiation Cytogenetics, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer,' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.
Wolff G; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Wieder A; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Szendroedi J; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Herzig S; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Ekim Üstünel B; Institute for Diabetes and Cancer (IDC), Helmholtz Diabetes Center, Helmholtz Center, Munich, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2022 Aug 27; Vol. 618, pp. 46-53. Date of Electronic Publication: 2022 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatic Stellate Cells*/metabolism
Hepatic Stellate Cells*/pathology
Liver Cirrhosis*/metabolism
Liver Cirrhosis*/pathology
Non-alcoholic Fatty Liver Disease*/metabolism
Non-alcoholic Fatty Liver Disease*/pathology
Transcription Factors*/metabolism
Transforming Growth Factor beta1*/metabolism
Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Humans
Czasopismo naukowe
Tytuł:
Ochratoxin a induces hepatic fibrosis through TGF-β receptor I/Smad2/3 signaling pathway.
Autorzy:
Chae SA; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Pyo MC; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Yoo HJ; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Lee KW; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.; Department of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Environmental toxicology [Environ Toxicol] 2022 Aug; Vol. 37 (8), pp. 2084-2095. Date of Electronic Publication: 2022 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis*/chemically induced
Liver Cirrhosis*/genetics
Liver Cirrhosis*/metabolism
Transforming Growth Factor beta*/metabolism
Epithelial-Mesenchymal Transition ; Fibrosis ; Humans ; Ochratoxins ; RNA, Messenger ; Receptors, Transforming Growth Factor beta/metabolism ; Signal Transduction ; Smad2 Protein/genetics ; Smad2 Protein/metabolism ; Transforming Growth Factor beta1/metabolism
Czasopismo naukowe
Tytuł:
Alcohol-associated fibrosis in females is mediated by female-specific activation of lysine demethylases KDM5B and KDM5C.
Autorzy:
Schonfeld M; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Averilla J; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Gunewardena S; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Weinman SA; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.; Liver Center, University of Kansas Medical Center, Kansas City, Kansas, USA.; Kansas City VA Medical Center, Kansas City, Missouri, USA.
Tikhanovich I; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Pokaż więcej
Źródło:
Hepatology communications [Hepatol Commun] 2022 Aug; Vol. 6 (8), pp. 2042-2057. Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Alcohol Drinking*/adverse effects
DNA-Binding Proteins*/genetics
Jumonji Domain-Containing Histone Demethylases*/genetics
Liver Cirrhosis*/enzymology
Liver Cirrhosis*/genetics
Lysine*/genetics
Animals ; Chromatin Immunoprecipitation ; Epigenesis, Genetic ; Female ; Histone Demethylases ; Male ; Mice
Czasopismo naukowe
Tytuł:
Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score.
Autorzy:
Åberg F; Transplantation and Liver Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Electronic address: .
Luukkonen PK; Minerva Foundation Institute for Medical Research, Helsinki, Finland; Department of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Department of Internal Medicine, Yale University, New Haven, CT, USA.
But A; Biostatistics Consulting, Department of Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Salomaa V; Finnish Institute for Health and Welfare, Finland.
Britton A; Institute of Epidemiology and Health Care, University College London, London, UK.
Petersen KM; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Balling M; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Nordestgaard BG; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark; Copenhagen City Heart Study, Frederiksberg Hospital, Copenhagen University Hospital, Frederiksberg, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Puukka P; Clinicum, University of Helsinki, Helsinki, Finland.
Männistö S; Finnish Institute for Health and Welfare, Finland.
Lundqvist A; Finnish Institute for Health and Welfare, Finland.
Perola M; Finnish Institute for Health and Welfare, Finland.
Jula A; Finnish Institute for Health and Welfare, Finland.
Färkkilä M; Helsinki University and Helsinki University Hospital, Abdominal Center, Helsinki, Finland.
Pokaż więcej
Źródło:
Journal of hepatology [J Hepatol] 2022 Aug; Vol. 77 (2), pp. 302-311. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis*
gamma-Glutamyltransferase*
Adult ; Aged ; Cohort Studies ; Humans ; Middle Aged ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł:
Artificial Intelligence-Based Feature Analysis of Ultrasound Images of Liver Fibrosis.
Autorzy:
Xie Y; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.; The First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Chen S; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.
Jia D; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.; The First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Li B; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.; The First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Zheng Y; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.
Yu X; Department of Gastroenterology, The 940 Hospital of Joint Logistic Support Force of PLA, Lanzhou 730050, China.
Pokaż więcej
Źródło:
Computational intelligence and neuroscience [Comput Intell Neurosci] 2022 Jul 30; Vol. 2022, pp. 2859987. Date of Electronic Publication: 2022 Jul 30 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Artificial Intelligence*
Liver Cirrhosis*/diagnostic imaging
Liver Cirrhosis*/pathology
Humans ; Neural Networks, Computer ; Ultrasonography
Czasopismo naukowe
Tytuł:
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients.
Autorzy:
Mijic M; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.
Saric I; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.
Delija B; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.
Lalovac M; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.
Sobocan N; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.; University of Zagreb, School of Medicine, Salata 3, Zagreb, Croatia.
Radetic E; University of Zagreb, School of Medicine, Salata 3, Zagreb, Croatia.
Martincevic D; University of Zagreb, School of Medicine, Salata 3, Zagreb, Croatia.
Filipec Kanizaj T; Department of Gastroenterology, University Hospital Merkur, Zajceva 19, Zagreb, Croatia.; University of Zagreb, School of Medicine, Salata 3, Zagreb, Croatia.
Pokaż więcej
Źródło:
Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2022 Jul 22; Vol. 2022, pp. 7831165. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Autoimmune Diseases*
Cholestasis*/drug therapy
End Stage Liver Disease*/surgery
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/surgery
Liver Transplantation*
Cholagogues and Choleretics/therapeutic use ; Humans ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Tytuł:
Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF- β Signaling.
Autorzy:
Qian K; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Lei X; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.; The First Affiliated Hospital, Department of Hepato-Biliary-Pancreatic Surgery, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Liu G; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Fang Y; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Xie C; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Wu X; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Liu Q; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Liu G; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Cao Z; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Zhang J; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Kuang T; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Yan L; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Fu J; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Du H; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Liu Z; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Chu Y; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Xu G; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.
Yamamoto H; Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan.
Mori M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Liang XM; Wellman Center for Photomedicine, Department of Medicine, Division of Endocrinology, Massachusetts General Hospital, VA Boston Healthcare System, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
Xu X; Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, The Second Xiangya Hospital, Central South University, Hunan Provincial Key Laboratory of Hepatobiliary Disease Research, Changsha, Hunan 410011, China.; Department of general surgery, Southern China Hospital, Health Science Center, Shenzhen University, No. 1, Fuxin Road, Pinghu Street, Longgang District, Shenzhen, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Jul 21; Vol. 2022, pp. 3100943. Date of Electronic Publication: 2022 Jul 21 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Liver*/metabolism
Liver*/pathology
Liver Cirrhosis*/chemically induced
Liver Cirrhosis*/genetics
Liver Cirrhosis*/metabolism
TRPV Cation Channels*/genetics
TRPV Cation Channels*/metabolism
Transforming Growth Factor beta1*/genetics
Transforming Growth Factor beta1*/metabolism
Animals ; Capsaicin/adverse effects ; Fibrosis ; Hepatic Stellate Cells/metabolism ; Hepatic Stellate Cells/pathology ; Humans ; Mice ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism
Czasopismo naukowe
Tytuł:
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Autorzy:
Graupera I; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación En Red de Enfermedades Hepáticas Y Digestivas (Ciberehd), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Thiele M; Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, and Institute for Clinical Research, University of Southern Denmark Odense, Odense, Denmark.
Ma AT; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Serra-Burriel M; Epidemiology, Statistics, and Prevention Institute, University of Zurich, Zurich, Switzerland.
Pich J; Clinical Trial Unit, Hospital Clínic, 08036, Barcelona, Spain.
Fabrellas N; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Caballeria L; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Metropolitana Nord, IDIAP Jordi Gol, ICS Institut Català de la Salut, Barcelona, Spain.
de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Grgurevic I; Department of Gastroenterology, Hepatology and Clinical Nutrition, University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
Reichert M; Department of Medicine II, Saarland University Medical Center, Homburg, Germany.
Roulot D; Unité d'Hépatologie, Hôpital Avicenne, AP-HP, Université Paris 13, Bobigny, France.
Schattenberg JM; Metabolic Liver Research Program, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg, Mainz, Germany.
Pericas JM; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR) , Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain.
Angeli P; Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine (DIMED), University-Teaching Hospital of Padova, Padua, Italy.
Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital, University College of London (UCL), London, UK.
Guha IN; NIHR Nottingham Biomedical Research University Mainz Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Garcia-Retortillo M; Liver Section, Gastroenterology Department, Hospital del Mar, Department of Medicine, IMIM, Barcelona, Spain.
Morillas RM; Liver Unit, Hospital Germans Trias i Pujol, IGTP, Badalona, Spain.
Hernández R; Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria, Barcelona, Spain.
Hoyo J; Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria, Barcelona, Spain.
Fuentes M; Institut Catala de la Salut (ICS). BCN. Ambit d'Atencio Primaria, Barcelona, Spain.
Madir A; Department of Gastroenterology, Hepatology and Clinical Nutrition, University Hospital Dubrava, University of Zagreb School of Medicine and Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.
Juanola A; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación En Red de Enfermedades Hepáticas Y Digestivas (Ciberehd), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Soria A; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Juan M; Clinical Trial Unit, Hospital Clínic, 08036, Barcelona, Spain.
Carol M; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación En Red de Enfermedades Hepáticas Y Digestivas (Ciberehd), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Diaz A; Department of Pathology. Centre of Biomedical Diagnosis. Hospital Cínic, Barcelona, Spain.
Detlefsen S; Department of Pathology, Odense University Hospital (OUH), University of Southern Denmark, Odense, Denmark.
Toran P; Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Metropolitana Nord, IDIAP Jordi Gol, ICS Institut Català de la Salut, Barcelona, Spain.
Fournier C; Echosens, Paris, France.
Llorca A; Echosens, Paris, France.
Newsome PN; National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK.
Manns M; Health Sciences, Hannover Medical School MHH, Hannover, Germany.
de Koning HJ; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
Serra-Burriel F; Barcelona Super Computing Center (BSC), Barcelona, Spain.
Cucchietti F; Barcelona Super Computing Center (BSC), Barcelona, Spain.
Arslanow A; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Metabolic Liver Research Program, Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg, Mainz, Germany.
Korenjak M; European Liver Patients' Association, Brussels, Belgium.
van Kleef L; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
Falcó JL; Genesis Biomed, Barcelona, Spain.
Kamath PS; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Karlsen TH; Oslo University hospital, Oslo, Norway.
Castera L; Department of Hepatology, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, Université de Paris, Paris, France.
Lammert F; Department of Medicine II, Saarland University Medical Center, Homburg, Germany.; Institute for Occupational Medicine and Public Health, Saarland University, Homburg, Germany.; Hannover Medical School (MHH), Hannover, Germany.
Krag A; Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, and Institute for Clinical Research, University of Southern Denmark Odense, Odense, Denmark.
Ginès P; Liver Unit Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. .; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. .; Centro de Investigación En Red de Enfermedades Hepáticas Y Digestivas (Ciberehd), Barcelona, Spain. .; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. .
Pokaż więcej
Corporate Authors:
LiverScreen Consortium investigators
Źródło:
BMC public health [BMC Public Health] 2022 Jul 19; Vol. 22 (1), pp. 1385. Date of Electronic Publication: 2022 Jul 19.
Typ publikacji:
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Elasticity Imaging Techniques*/methods
Liver Cirrhosis*/diagnostic imaging
Liver Cirrhosis*/pathology
Mass Screening*/methods
Biopsy ; Europe ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz